NPI: 1164495461 · BIRMINGHAM, AL 35218 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/08/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/08/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 34,643 | $463K |
| 2019 | 23,619 | $357K |
| 2020 | 20,647 | $340K |
| 2021 | 15,789 | $215K |
| 2022 | 13,508 | $197K |
| 2023 | 6,831 | $101K |
| 2024 | 4,384 | $60K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 33,472 | 2,469 | $1.15M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 40,825 | 1,843 | $473K |
| J1756 | Injection, iron sucrose, 1 mg | 9,423 | 1,999 | $43K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 716 | 367 | $21K |
| 83970 | 1,657 | 1,437 | $18K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 21,127 | 1,543 | $7K |
| 82108 | 657 | 576 | $5K | |
| A4657 | Syringe, with or without needle, each | 2,276 | 1,888 | $5K |
| 83550 | 857 | 677 | $2K | |
| 82728 | 889 | 752 | $2K | |
| 85045 | 1,522 | 1,394 | $2K | |
| 83540 | 994 | 797 | $2K | |
| 85041 | 1,738 | 1,535 | $1K | |
| 85048 | 1,732 | 1,532 | $1K | |
| 90674 | 104 | 93 | $500.02 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 1,015 | 677 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 73 | 72 | $0.00 |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 344 | 108 | $0.00 |